Form F-4 - Registration of securities, foreign private issuers, business combinations:
SEC Accession No. 0001193125-25-177520
Filing Date
2025-08-11
Accepted
2025-08-11 08:43:04
Documents
23

Document Format Files

Seq Description Document Type Size
1 F-4 d847647df4.htm F-4 2101736
2 EX-8.1 d847647dex81.htm EX-8.1 9861
3 EX-23.1 d847647dex231.htm EX-23.1 2158
4 EX-23.2 d847647dex232.htm EX-23.2 1411
5 EX-23.3 d847647dex233.htm EX-23.3 2428
6 EX-99.1 d847647dex991.htm EX-99.1 218123
7 EX-99.2 d847647dex992.htm EX-99.2 16523
8 EX-99.3 d847647dex993.htm EX-99.3 28688
9 EX-99.4 d847647dex994.htm EX-99.4 23019
10 EX-FILING FEES d847647dexfilingfees.htm   iXBRL EX-FILING FEES 19041
11 GRAPHIC g847647g0805042350755.jpg GRAPHIC 1504
12 GRAPHIC g847647g50w55.jpg GRAPHIC 53950
13 GRAPHIC g847647g62v83.jpg GRAPHIC 1874
  Complete submission text file 0001193125-25-177520.txt   2625725

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT d847647dexfilingfees_htm.xml XML 5723
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: F-4 | Act: 33 | File No.: 333-289468 | Film No.: 251200357
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)